Previous Article | Next Article 
Journal of Clinical Microbiology, March 2001, p. 1140-1143, Vol. 39, No. 3
Laboratory of Enteric Pathogens, National
Public Health Institute, FIN-00300 Helsinki,
Finland,1 and Laboratory of Enteric
Pathogens, Central Public Health Laboratory, Colindale,
England2
Received 24 July 2000/Returned for modification 22 October
2000/Accepted 11 December 2000
This study examined Shiga toxin-producing Escherichia
coli (STEC) O157, using phage typing, pulsed-field gel
electrophoresis, and typing of Shiga toxin variant genes by PCR with
restriction fragment length polymorphism in an epidemiological survey
of STEC O157 isolated from humans in Finland between 1990 and 1999.
Human infections caused by Shiga
toxin-producing Escherichia coli (STEC) O157 have been
reported from over 30 countries on six continents (12). In
Finland, with a population of 5.1 million, the incidence rate of STEC
O157 infections rose from 0.06 in 1990 (9) to 1.0 in 1997 and then decreased to 0.3 in 1999 (13). The only recorded
STEC O157 outbreak in Finland occurred in 1997 (14).
Pulsed-field gel electrophoresis (PFGE) has been widely used for
subtyping of STEC O157 (6). However, an internationally standardized library of PFGE fingerprints has not yet been created, in
contrast to phage typing for STEC O157 (1, 10). In this study, 105 STEC O157:H7 and O157:H For phage typing, the bacteria were grown in
double-strength nutrient broth (Difco Laboratories, Detroit,
Mich.) shaken for 1.5 h at 37°C, flooded onto double-strength
nutrient agar plates (Difco), and phage typed (1, 10). The
results were interpreted according to a phage type list of 66 confirmed
and 14 provisional phage types. A result of RDNC (for reacts but does
not conform) was confirmed by phage typing five additional colonies of
the strain.
In PFGE, bacterial growth on nutrient agar was suspended in TEN buffer
(0.1 M Tris-HCl, 0.15 M NaCl, 0.1 M EDTA, pH 7.5) to an
A600 of 0.280 to 0.310. The suspension was
embedded equally in 1.8% InCert agarose (FMC BioProducts, Rockland,
Maine) and digested overnight with 0.15 mg of proteinase K (Boehringer
Mannheim, Indianapolis, Ind.) per ml at 50°C in 3 ml of ES buffer
(0.5 M EDTA, 1% N-lauroylsarcosine). The plugs were washed
as described previously (9). The PFGE method and the
library of PFGE types were standardized nationally (L. Rantala, M. Saari, S. Hallanvuo, A. Siitonen, and T. Honkanen-Buzalski, Abstr.
Nordic PFGE meeting, 25-26, 2000). The PFGE types were coded from 1.1 to 1.59.
PCR-RFLP was executed as described previously (4, 11) with
minor modifications. A loopful of bacteria on sorbitol-MacConkey plates
was suspended in 500 µl of sterile water, boiled for 5 min, and
centrifuged briefly, and 1 µl was used as a template. In the PCR, the
final elongation was for 10 min at 72°C. The amplified DNA was
restricted with 20 U of HincII and AccI enzymes
(New England Biolabs) (4).
Of the 105 strains studied, 98 (93%) belonged to nine confirmed phage
types (PTs): PT2,
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.3.1140-1143.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Phage Types and Genotypes of Shiga Toxin-Producing
Escherichia coli O157 in Finland
ABSTRACT
Top
Abstract
Text
References
TEXT
Top
Abstract
Text
References
strains isolated from
cultures sent from Finnish hospital laboratories to the Laboratory of
Enteric Pathogens, National Public Health Institute (9),
during 1990 to 1999 were phage typed, genotyped by PFGE, and
investigated for Shiga toxin variant genes by PCR with restriction
fragment length polymorphism. In addition, the relevant patient data,
including recent foreign travel, were collected on a special form
accompanying the isolate.
4, 8, 14, 21/28, 34, 49, 50 and 88
(Table 1).
The most common PT was PT2, representing
56% of all isolates, followed by PT4 (11%), PT49 (10%), and PT8
(6%). Seven strains (7%) did not conform to any published phage type and were designated RDNC, which formed three distinct reaction patterns. Of all strains, 93 isolates (89%) were of domestic origin. Among these, the predominant PT was PT2 (62%; 58 isolates), followed by PT49 (11%; 10 isolates) and PT4 (10%; 9 isolates). Three strains (3%) were designated RDNC. In PFGE, the isolates of domestic origin were distributed in 24 types. The main types were 1.1 (53%), 1.3 (5%), and 1.12 (4%). Twelve isolates were associated with recent travel abroad. Among these isolates, the PT distribution was PT2 (8%),
PT4 (25%), PT8 (33%), and RDNC (33%). By PFGE, 10 types were
detected, of which two types (1.5 and 1.47) were also found indigenously (Table 1, Fig. 1). Among all
isolates, the most common PT-PFGE combinations were PT2/1.1 (46%),
PT49/1.12 (4%), and PT4/1.47 (4%). In PCR-RFLP, the majority of the
strains (70%; 74 strains) were positive for
stx2 and either stx2c,
stx2vha, or stx2vOX393.
These genes associated mainly with PT2/1.1 (48 strains), PT4 (5 strains), and RDNC (3 strains). The strains carrying stx2c, stx2vha, or
stx2vOX393 only were all of foreign origin; they
were from Turkey (PT8/1.9), Spain (RDNC3/1.11), and Greece (RDNC3/1.59). The five strains carrying stx1 and
stx2c, stx2vha, or
stx2vOX393 all belonged to PT8; three of them
were associated with recent travel to Spain (PT8/1.52), Turkey
(PT8/1.29), and the Czech Republic (PT8/1.30).
TABLE 1.
Characteristics of STEC O157:H7 and O157:H
isolates in Finland from 1990 to 2000
View larger version (113K):
[in a new window]
FIG. 1.
PFGE fingerprint patterns of the STEC O157 isolates of
foreign and of domestic origin in Finland. Lanes 1, 8, and 15, bacteriophage lambda ladder PFG marker 340 (New England Biolabs Inc.,
Beverly, Mass.); lane 2, type PT8/1.30 (Czech Republic); lane 3, type
RDNC 3/1.49 (Tunisia); lane 4, type RDNC 3/1.11 (Spain); lane 5, type
PT8/1.52 (Spain); lane 6, type PT8/1.9 (Turkey); lane 7, type PT8/1.29
(Turkey); lane 9, type RDNC 3/1.59 (Greece); lane 10, type PT2/1.5
(Finland and Russia); lane 11, type PT4/1.47 (Finland and Sweden); lane
12, type RDNC 3/1.48 (Greece); lane 13, type PT8/1.32 (Finland); lane
14, O157:H7 control strain (no. G5244) from the Centers for Disease
Control and Prevention.
The distribution of PTs in Finland was similar to that found in several
other countries, especially in Europe (2, 3, 7, 8, 15).
While the range of PT and PFGE types isolated from human infections in
Finland indicates several domestic sources for STEC O157 infections,
only one sporadic infection could be linked to a known food item,
unpasteurized milk (16). However, various food items or
environmental sources have caused STEC O157 infections worldwide
(12). Based on these data, further studies of the
prevalence of STEC O157 bacteria in Finland will be needed. In this
study, 70% of the strains of the most common PT (PT2) possessed
stx2 and stx2c,
stx2vha, or
stx2vOX393. These strains were isolated mainly
during the STEC outbreak in Finland in July 1997 (14),
although this subtype was seen for the first time in May 1997 (9). The reason for the emergence of these strains can
only be speculated on; it took place about 2 years after Finland joined
the European Union (EU). In fact, the swift emergence and similarity of
the strains in Finland and other European countries even speak for the
effect of EU on this issue. For example, in Great Britain, PT2 strains
possessing stx2 and stx2c
have caused several outbreaks (18). The other common
domestic types, PT4 and PT49, have also been common in Great Britain
(17). Also, sorbitol-positive O157:H strains
of PT88 carrying the stx2 gene were found in our
study. Similar strains have caused a large outbreak in Germany
(2) and have been isolated in the Czech Republic
(5). In infections of foreign origin, strains of PT8
carrying stx1 and stx2c,
stx2vha, or
stx2vOX393 have predominated in Finland.
Interestingly, PT8 strains possessing the stx1
and stx2 genes have also been found in The
Netherlands and Great Britain (7, 17).
This study used STEC O157 phage typing for the first time as an extensive epidemiological surveillance method in Finland. The information gained on the PT distribution in Finland may help to trace O157 infections at the EU level and help to assess the need to standardize new PTs indicated by RDNC.
| |
ACKNOWLEDGMENTS |
|---|
We thank Bernard Rowe and Henry Smith, Central Public Health Laboratory, Colindale, London, England, for cooperation in setting up the phage typing of STEC O157 in Finland. We also thank Sirkku Waarala and Tarja Heiskanen for excellent laboratory assistance.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: National Public Health Institute, Laboratory of Enteric Pathogens, Mannerheimintie 166, FIN-00300 Helsinki, Finland. Phone: 358-9-47448245. Fax: 358-9-47448238. E-mail: anja.siitonen{at}KTL.fi.
| |
REFERENCES |
|---|
|
Top
Abstract
Text
References
|
|---|
| 1. | Ahmed, R., C. Bopp, A. Borczyk, and S. Kasatiya. 1987. Phage-typing scheme for Escherichia coli O157:H7. J. Infect. Dis. 155:806-809[Medline]. |
| 2. |
Ammon, A.,
L. R. Petersen, and H. Karch.
1999.
A large outbreak of hemolytic uremic syndrome caused by an unusual sorbitol-fermenting strain of Escherichia coli O157:H.
J. Infect. Dis.
179:1274-1277[CrossRef][Medline].
|
| 3. |
Barrett, T. J.,
H. Lior,
J. H. Green,
R. Khakhria,
J. G. Wells,
B. P. Bell,
K. D. Greene,
J. Lewis, and P. M. Griffin.
1994.
Laboratory investigation of a multistate food-borne outbreak of Escherichia coli O157:H7 by using pulsed-field gel electrophoresis and phage typing.
J. Clin. Microbiol.
32:3013-3017 |
| 4. | Bastian, S. N., I. Carle, and F. Grimont. 1998. Comparison of 14 PCR systems for the detection and subtyping of stx genes in Shiga-toxin-producing Escherichia coli. Res. Microbiol. 149:457-472[Medline]. |
| 5. |
Bielaszewska, M.,
H. Schmidt,
M. A. Karmali,
R. Khakhria,
J. Janda,
K. Blahova, and H. Karch.
1998.
Isolation and characterization of sorbitol-fermenting Shiga toxin (verocytotoxin)-producing Escherichia coli O157:H- strains in the Czech Republic.
J. Clin. Microbiol.
36:2135-2137 |
| 6. | Grif, K., H. Karch, C. Schneider, F. D. Daschner, L. Beutin, T. Cheasty, H. Smith, B. Rowe, M. P. Dierich, and F. Allerberger. 1998. Comparative study of five different techniques for epidemiological typing of Escherichia coli O157. Diagn. Microbiol. Infect. Dis. 32:165-176[CrossRef][Medline]. |
| 7. | Heuvelink, A. E., N. C. A. J. van de Kar, J. F. G. M. Meis, L. A. H. Monnens, and W. J. G. Melchers. 1995. Characterization of Verocytotoxin-producing Escherichia coli O157 isolates from patients with haemolytic uraemic syndrome in Western Europe. Epidemiol. Infect. 115:1-14[Medline]. |
| 8. | Izumiya, H., T. Masuda, R. Ahmed, R. Khakria, A. Wada, J. Terajima, K. Itoh, W. M. Johnson, H. Konuma, K. Shinagawa, K. Tamura, and H. Watanabe. 1998. Combined use of bacteriophage typing and pulsed-field gel electrophoresis in the epidemiological analysis of Japanese isolates of enterohemorrhagic Escherichia coli O157:H7. Microbiol. Immunol. 42:515-519[Medline]. |
| 9. |
Keskimäki, M.,
M. Saari,
T. Heiskanen, and A. Siitonen.
1998.
Shiga toxin-producing Escherichia coli in Finland from 1990 through 1997: prevalence and characteristics of isolates.
J. Clin. Microbiol.
36:3641-3646 |
| 10. | Khakhria, R., D. Duck, and H. Lior. 1990. Extended phage-typing scheme for Escherichia coli O157:H7. Epidemiol. Infect. 105:511-520[Medline]. |
| 11. | Lin, Z., H. Kurazono, S. Yamasaki, and Y. Takeda. 1993. Detection of various variant verotoxin genes in Escherichia coli by polymerase chain reaction. Microbiol. Immunol. 37:543-548[Medline]. |
| 12. | Mead, P. S., and P. M. Griffin. 1998. Escherichia coli O157:H7. Lancet. 352:1207-1212[CrossRef][Medline]. |
| 13. | National Public Health Institute. 2000. Infectious diseases in Finland 1995-1999. Publication series B4/2000. National Public Health Institute, Helsinki, Finland. |
| 14. | Paunio, M., R. Pebody, M. Keskimäki, M. Kokki, P. Ruutu, S. Oinonen, V. Vuotari, A. Siitonen, E. Lahti, and P. Leinikki. 1999. Swimming associated outbreak of enterohemorrhagic Escherichia coli (EHEC) O157:H7. Epidemiol. Infect. 122:1-5[CrossRef][Medline]. |
| 15. | Smith, H. R., B. Rowe, G. K. Adak, and W. J. Reilly. 1998. Shiga toxin (Verocytotoxin)-producing Escherichia coli in the United Kingdom, p. 49-58. In J. B. Kaper, and A. D. O'Brien (ed.), Escherichia coli O157:H7 and other shiga toxin-producing E. coli strains. ASM Press, Washington, D.C. |
| 16. | Tast, E., M. Keskimäki, V. Myllys, P. Suomala, M. Saari, A. Siitonen, and T. Honkanen-Buzalski. 1997. Vero cytotoxin producing Escherichia coli O157:H7 infection in a 6-year-old child associated with consumption of unpasteurised milk, p. 202. In Proceedings of World Congress on Food Hygiene. Wageningen Pers, Wageningen, The Netherlands. |
| 17. | Thomas, A., T. Cheasty, J. A. Frost, H. Chart, H. R. Smith, and B. Rowe. 1996. Vero cytotoxin-producing Escherichia coli, particularly serogroup O157, associated with human infections in England and Wales: 1992-4. Epidemiol. Infect. 117:1-10[Medline]. |
| 18. | Willshaw, G. A., H. R. Smith, T. Cheasty, P. G. Wall, and B. Rowe. 1997. Vero cytotoxin-producing Escherichia coli O157 outbreaks in England and Wales, 1995: phenotypic methods and genotypic subtyping. Emerg. Infect. Dis. 3:561-565[Medline]. |
Journal of Clinical Microbiology, March 2001, p. 1140-1143, Vol. 39, No. 3
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.3.1140-1143.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Shima, K., Terajima, J., Sato, T., Nishimura, K., Tamura, K., Watanabe, H., Takeda, Y., Yamasaki, S.
(2004). Development of a PCR-Restriction Fragment Length Polymorphism Assay for the Epidemiological Analysis of Shiga Toxin-Producing Escherichia coli. J. Clin. Microbiol.
42: 5205-5213
[Abstract] [Full Text] -
Mora, A., Blanco, M., Blanco, J. E., Alonso, M. P., Dhabi, G., Thomson-Carter, F., Usera, M. A., Bartolome, R., Prats, G., Blanco, J.
(2004). Phage Types and Genotypes of Shiga Toxin-Producing Escherichia coli O157:H7 Isolates from Humans and Animals in Spain: Identification and Characterization of Two Predominating Phage Types (PT2 and PT8). J. Clin. Microbiol.
42: 4007-4015
[Abstract] [Full Text] -
Blanco, J., Blanco, M., Blanco, J. E., Mora, A., Gonzalez, E. A., Bernardez, M. I., Alonso, M. P., Coira, A., Rodriguez, A., Rey, J., Alonso, J. M., Usera, M. A.
(2003). Verotoxin-Producing Escherichia coli in Spain: Prevalence, Serotypes, and Virulence Genes of O157:H7 and Non-O157 VTEC in Ruminants, Raw Beef Products, and Humans. Exp. Biol. Med.
228: 345-351
[Abstract] [Full Text] -
Ratiner, Y. A., Salmenlinna, S., Eklund, M., Keskimaki, M., Siitonen, A.
(2003). Serology and Genetics of the Flagellar Antigen of Escherichia coli O157:H7a,7c. J. Clin. Microbiol.
41: 1033-1040
[Abstract] [Full Text] -
Lahti, E., Ruoho, O., Rantala, L., Hanninen, M.-L., Honkanen-Buzalski, T.
(2003). Longitudinal Study of Escherichia coli O157 in a Cattle Finishing Unit. Appl. Environ. Microbiol.
69: 554-561
[Abstract] [Full Text] -
Eklund, M., Leino, K., Siitonen, A.
(2002). Clinical Escherichia coli Strains Carrying stx Genes: stx Variants and stx-Positive Virulence Profiles. J. Clin. Microbiol.
40: 4585-4593
[Abstract] [Full Text] -
Eklund, M., Scheutz, F., Siitonen, A.
(2001). Clinical Isolates of Non-O157 Shiga Toxin-Producing Escherichia coli: Serotypes, Virulence Characteristics, and Molecular Profiles of Strains of the Same Serotype. J. Clin. Microbiol.
39: 2829-2834
[Abstract] [Full Text]
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»